Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature

References

• Agrawal M, Saraf S, Saraf S, et al. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opin Drug Deliv. 2018;15(6):589–617.
   PubMed Web of Science ®Google Scholar
• Singh AV, Chandrasekar V, Janapareddy P, et al. Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: advances in Design, Controlled Maneuvering, and Targeting of the Barriers. ACS Chem Neurosci. 2021;1:448–455.
   Google Scholar
• Aderibigbe BA. In situ-based gels for nose to brain delivery for the treatment of neurological diseases. Pharmaceutics. 2018;10(2):40. doi:10.3390/pharmaceutics10020040
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Saraf S, et al. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Controlled Release. 2020;24:12–85.
   Google Scholar
• Persano F, Batasheva S, Fakhrullina G, Gigli G, Leporatti S, Fakhrullin R. Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders. J Mater Chem B. 2021;9(12):2756–2784.
   PubMed Web of Science ®Google Scholar
• Bandopadhyay S, Manchanda S, Chandra A, Ali J, Deb PK. Overview of different carrier systems for advanced drug delivery. Drug Delivery Systems. 2020;179–233.
   Google Scholar
• Jena L, McErlean E, McCarthy H. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme. Drug Deliv Transl Res. 2020;10(2):304–318. doi:10.1007/s13346-019-00679-2
   PubMed Web of Science ®Google Scholar
• Zhou Y, Peng Z, Seven ES, Leblanc RM. Crossing the blood-brain barrier with nanoparticles. J Controlled Release. 2018;270:290–303. doi:10.1016/j.jconrel.2017.12.015
   PubMed Web of Science ®Google Scholar
• Ding S, Khan AI, Cai X, et al. Overcoming blood–brain barrier transport: advances in nanoparticle-based drug delivery strategies. Materials Today. 2020;37:112–125. doi:10.1016/j.mattod.2020.02.001
   Web of Science ®Google Scholar
• Wu X, Yang H, Yang W, et al. Nanoparticle-based diagnostic and therapeutic systems for brain tumors. J Mater Chem B. 2019;7(31):4734–4750. doi:10.1039/C9TB00860H
   PubMed Web of Science ®Google Scholar
• Zottel A, Videtič Paska A, Jovčevska I. Nanotechnology meets oncology: nanomaterials in brain cancer research, diagnosis and therapy. Materials. 2019;12(10):1588. doi:10.3390/ma12101588
   PubMed Web of Science ®Google Scholar
• Gonzalez-Carter D, Liu X, Tockary TA, et al. Targeting nanoparticles to the brain by exploiting the blood–brain barrier impermeability to selectively label the brain endothelium. Proce Nat Acad Sci. 2020;117(32):19141–19150. doi:10.1073/pnas.2002016117
   PubMedGoogle Scholar
• Choquet D, Sainlos M, Sibarita J-B. Advanced imaging and labelling methods to decipher brain cell organization and function. Nat Rev Neurosci. 2021;22(4):237–255.
   PubMedGoogle Scholar
• Zhang L, Yao K, Wang Y, et al. Brain-Targeted Dual Site-Selective Functionalized Poly (β-Amino Esters) Delivery Platform for Nerve Regeneration. Nano Lett. 2021;21(7):3007–3015. doi:10.1021/acs.nanolett.1c00175
   PubMedGoogle Scholar
• Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13:528. doi:10.3389/fncel.2019.00528
   PubMed Web of Science ®Google Scholar
• Chodobski A, Zink BJ, Szmydynger-Chodobska J. Blood–brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res. 2011;2(4):492–516. doi:10.1007/s12975-011-0125-x
   PubMed Web of Science ®Google Scholar
• Cantrill CA, Skinner RA, Rothwell NJ, Penny JI. An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood–brain barrier model. Brain Res. 2012;1479:17–30. doi:10.1016/j.brainres.2012.08.031
   PubMed Web of Science ®Google Scholar
• Lam C, Hansen E, Janson C, Bryan A, Hubel A. The characterization of arachnoid cell transport II: paracellular transport and blood–cerebrospinal fluid barrier formation. Neuroscience. 2012;222:228–238. doi:10.1016/j.neuroscience.2012.06.065
   PubMedGoogle Scholar
• Ayloo S, Gu C. Transcytosis at the blood–brain barrier. Curr Opin Neurobiol. 2019;57:32–38. doi:10.1016/j.conb.2018.12.014
   PubMed Web of Science ®Google Scholar
• Lu W. Adsorptive-mediated brain delivery systems. Curr Pharm Biotechnol. 2012;13(12):2340–2348. doi:10.2174/138920112803341851
   PubMed Web of Science ®Google Scholar
• Stewart PA. Endothelial vesicles in the blood–brain barrier: are they related to permeability? Cell Mol Neurobiol. 2000;20(2):149–163. doi:10.1023/A:1007026504843
   PubMed Web of Science ®Google Scholar
• Li J, Kataoka K. Chemo-physical strategies to advance the in vivo functionality of targeted nanomedicine: the next generation. J Am Chem Soc. 2020;143(2):538–559. doi:10.1021/jacs.0c09029
   PubMedGoogle Scholar
• Mizrahy S, Gutkin A, Decuzzi P, Peer D. Targeting central nervous system pathologies with nanomedicines. J Drug Target. 2019;27(5–6):542–554. doi:10.1080/1061186X.2018.1533556
   PubMed Web of Science ®Google Scholar
• Kopeček J, Kopečková P. HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev. 2010;62(2):122–149. doi:10.1016/j.addr.2009.10.004
   PubMed Web of Science ®Google Scholar
• Li J, Han Y, Chen Q, et al. Dual endogenous stimuli-responsive polyplex micelles as smart two-step delivery nanocarriers for deep tumor tissue penetration and combating drug resistance of cisplatin. J Mater Chem B. 2014;2(13):1813–1824. doi:10.1039/C3TB21383H
   PubMedGoogle Scholar
• Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting strategies for tissue-specific drug delivery. Cell. 2020;181(1):151–167. doi:10.1016/j.cell.2020.02.001
   PubMed Web of Science ®Google Scholar
• Karimi M, Sahandi Zangabad P, Baghaee-Ravari S, Ghazadeh M, Mirshekari H, Hamblin MR. Smart nanostructures for cargo delivery: uncaging and activating by light. J Am Chem Soc. 2017;139(13):4584–4610. doi:10.1021/jacs.6b08313
   PubMed Web of Science ®Google Scholar
• Ahlawat J, Guillama Barroso G, Masoudi Asil S, et al. Nanocarriers as potential drug delivery candidates for overcoming the blood–brain barrier: challenges and possibilities. ACS Omega. 2020;5(22):12583–12595. doi:10.1021/acsomega.0c01592
   PubMed Web of Science ®Google Scholar
• Sengul AB, Asmatulu E. Toxicity of metal and metal oxide nanoparticles: a review. Environ Chem Lett. 2020;2:1–25.
   Google Scholar
• Quader S, Kataoka K. Nanomaterial-enabled cancer therapy. Mol Therapy. 2017;25(7):1501–1513. doi:10.1016/j.ymthe.2017.04.026
   PubMed Web of Science ®Google Scholar
• Jain K. Nanobiotechnology-based drug delivery to the central nervous system. Neurodegenerative Dis. 2007;4(4):287–291. doi:10.1159/000101884
   PubMed Web of Science ®Google Scholar
• Teleanu DM, Chircov C, Grumezescu AM, Volceanov A, Teleanu RI. Impact of nanoparticles on brain health: an up to date overview. J Clin Med. 2018;7(12):490. doi:10.3390/jcm7120490
   PubMed Web of Science ®Google Scholar
• Gatoo MA, Naseem S, Arfat MY, Mahmood Dar A, Qasim K, Zubair S. Physicochemical properties of nanomaterials: implication in associated toxic manifestations. Biomed Res Int. 2014;2014:4598.
   Google Scholar
• Yasui T, Kaji N, Baba Y. Nanobiodevices for biomolecule analysis and imaging. Annu Rev Analytical Chem. 2013;6:83–96. doi:10.1146/annurev-anchem-062012-092619
   PubMedGoogle Scholar
• Frank D, Tyagi C, Tomar L, et al. Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int J Nanomedicine. 2014;9:589.
   PubMed Web of Science ®Google Scholar
• Petkar KC, Chavhan SS, Agatonovik-Kustrin S, Sawant K. Nanostructured materials in drug and gene delivery: a review of the state of the art. Critical Rev Therapeutic Drug Carrier Sys. 2011;28(2). doi:10.1615/CritRevTherDrugCarrierSyst.v28.i2.10
   Google Scholar
• Montet X, Funovics M, Montet-Abou K, Weissleder R, Josephson L. Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem. 2006;49(20):6087–6093. doi:10.1021/jm060515m
   PubMedGoogle Scholar
• Shi D, Mi G, Shen Y, Webster TJ. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood–brain barrier. Nanoscale. 2019;11(32):15057–15071. doi:10.1039/C9NR03931G
   PubMed Web of Science ®Google Scholar
• Soliman GM, Sharma R, Choi AO, et al. Tailoring the efficacy of nimodipine drug delivery using nanocarriers based on A2B miktoarm star polymers. Biomaterials. 2010;31(32):8382–8392. doi:10.1016/j.biomaterials.2010.07.039
   PubMedGoogle Scholar
• Xu X, Li J, Han S, et al. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. Eur J Pharmaceutical Sci. 2016;88:178–190. doi:10.1016/j.ejps.2016.02.015
   PubMed Web of Science ®Google Scholar
• Zhu Y, Liu C, Pang Z. Dendrimer-based drug delivery systems for brain targeting. Biomolecules. 2019;9(12):790. doi:10.3390/biom9120790
   PubMed Web of Science ®Google Scholar
• Abourehab MA, Ahmed OA, Balata GF, Almalki WH. Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood–brain barrier. Int J Nanomedicine. 2018;13:3679. doi:10.2147/IJN.S168148
   PubMed Web of Science ®Google Scholar
• Yang R, Zheng Y, Wang Q, Zhao L. Curcumin-loaded chitosan–bovine serum albumin nanoparticles potentially enhanced Aβ 42 phagocytosis and modulated macrophage polarization in Alzheimer’s disease. Nanoscale Res Lett. 2018;13(1):1–9. doi:10.1186/s11671-018-2759-z
   PubMedGoogle Scholar
• Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM. Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem. 2009;284(11):6972–6981. doi:10.1074/jbc.M805956200
   PubMed Web of Science ®Google Scholar
• Gonzalez-Carter DA, Ong ZY, McGilvery CM, Dunlop IE, Dexter DT, Porter AE. L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles. Nanomedicine. 2019;15(1):1–11. doi:10.1016/j.nano.2018.08.011
   PubMedGoogle Scholar
• Li S, Su W, Wu H, et al. Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids. Nat Biomed Eng. 2020;4(7):704–716. doi:10.1038/s41551-020-0540-y
   PubMed Web of Science ®Google Scholar
• Paris-Robidas S, Brouard D, Emond V, Parent M, Calon F. Internalization of targeted quantum dots by brain capillary endothelial cells in vivo. J Cerebral Blood Flow Metab. 2016;36(4):731–742. doi:10.1177/0271678X15608201
   PubMedGoogle Scholar
• Chauhan SB, Gupta V. Recent advances in liposome. Res J Pharm Tech. 2020;13:2051–2056.
   Google Scholar
• Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30(11):592–599. doi:10.1016/j.tips.2009.08.004
   PubMed Web of Science ®Google Scholar
• Li M, Du C, Guo N, et al. Composition design and medical application of liposomes. Eur J Med Chem. 2019;164:640–653. doi:10.1016/j.ejmech.2019.01.007
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145–160. doi:10.1038/nrd1632
   PubMed Web of Science ®Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975. doi:10.2147/IJN.S68861
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 2006;1(3):297.
   PubMed Web of Science ®Google Scholar
• Riaz MK, Riaz MA, Zhang X, et al. Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Int J Mol Sci. 2018;19(1):195. doi:10.3390/ijms19010195
   PubMed Web of Science ®Google Scholar
• Lakkadwala S, Dos Santos Rodrigues B, Sun C, Singh J. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma. J Controlled Release. 2019;307:247–260. doi:10.1016/j.jconrel.2019.06.033
   PubMed Web of Science ®Google Scholar
• Beltrán-Gracia E, López-Camacho A, Higuera-Ciapara I, Velázquez-Fernández JB, Vallejo-Cardona AA. Nanomedicine review: clinical developments in liposomal applications. Cancer Nanotechnol. 2019;10(1):1–40. doi:10.1186/s12645-019-0055-y
   Web of Science ®Google Scholar
• Xing H, Hwang K, Lu Y. Recent developments of liposomes as nanocarriers for theranostic applications. Theranostics. 2016;6(9):1336. doi:10.7150/thno.15464
   PubMed Web of Science ®Google Scholar
• Lakkadwala S, Singh J. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model. Colloids Surf B Biointerfaces. 2019;173:27–35. doi:10.1016/j.colsurfb.2018.09.047
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, Feng -S-S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm. 2011;421(2):332–340. doi:10.1016/j.ijpharm.2011.09.045
   PubMed Web of Science ®Google Scholar
• Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W. Cyclic RGD conjugated poly (ethylene glycol)-co-poly (lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Controlled Release. 2010;143(1):136–142. doi:10.1016/j.jconrel.2009.12.020
   PubMed Web of Science ®Google Scholar
• Qiao Y, Wan J, Zhou L, et al. Stimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(1):e1527.
   PubMed Web of Science ®Google Scholar
• Postma T, Heimans J, Luykx S, et al. A Phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma. Ann Oncol. 2000;11(4):409–413. doi:10.1023/A:1008376123066
   PubMedGoogle Scholar
• Chis AA, Dobrea C, Morgovan C, et al. Applications and Limitations of Dendrimers in Biomedicine. Molecules. 2020;25(17):3982. doi:10.3390/molecules25173982
   PubMed Web of Science ®Google Scholar
• Nanjwade BK, Bechra HM, Derkar GK, Manvi F, Nanjwade VK. Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharmaceutical Sci. 2009;38(3):185–196. doi:10.1016/j.ejps.2009.07.008
   PubMed Web of Science ®Google Scholar
• Caminade A-M, Turrin C-O. Dendrimers for drug delivery. J Mater Chem B. 2014;2(26):4055–4066. doi:10.1039/C4TB00171K
   PubMed Web of Science ®Google Scholar
• Madaan K, Kumar S, Poonia N, Lather V, Pandita D. Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci. 2014;6(3):139. doi:10.4103/0975-7406.130965
   PubMedGoogle Scholar
• Noriega-Luna B, Godínez LA, Rodríguez FJ, Rodríguez A. Applications of dendrimers in drug delivery agents, diagnosis, therapy, and detection. J Nanomater. 2014;2014. doi:10.1155/2014/507273
   Google Scholar
• Lloveras V, Vidal-Gancedo J. Polyphosphorhydrazone-Based Radical Dendrimers. Molecules. 2021;26(5):1230. doi:10.3390/molecules26051230
   PubMedGoogle Scholar
• Nguyen DH, Bach LG, Nguyen Tran D-H, et al. Partial surface modification of low generation polyamidoamine dendrimers: gaining insight into their potential for improved carboplatin delivery. Biomolecules. 2019;9(6):214. doi:10.3390/biom9060214
   PubMedGoogle Scholar
• Rajani C, Borisa P, Karanwad T, et al. Cancer-targeted chemotherapy: emerging role of the folate anchored dendrimer as drug delivery nanocarrier. Pharmaceutical App Dendrimers. 2020;151–198.
   Google Scholar
• Santos AICFd. Dendrimers as Pharmaceutical Excipients. Universidade de Coimbra; 2019.
   Google Scholar
• Parajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK, Dhakar RC. Potential application of dendrimers in drug delivery: a concise review and update. J Drug Delivery Therapeutics. 2016;6(2):71–88. doi:10.22270/jddt.v6i2.1195
   Google Scholar
• Katare YK, Daya RP, Sookram Gray C, et al. Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer. Mol Pharm. 2015;12(9):3380–3388. doi:10.1021/acs.molpharmaceut.5b00402
   PubMedGoogle Scholar
• Dhanikula RS, Hammady T, Hildgen P. On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood–brain barrier model. J Pharm Sci. 2009;98(10):3748–3760. doi:10.1002/jps.21669
   PubMedGoogle Scholar
• Albertazzi L, Gherardini L, Brondi M, et al. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. Mol Pharm. 2013;10(1):249–260. doi:10.1021/mp300391v
   PubMed Web of Science ®Google Scholar
• Kannan S, Dai H, Navath RS, et al. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med. 2012;4(130):130ra46–ra46. doi:10.1126/scitranslmed.3003162
   PubMedGoogle Scholar
• Liu C, Zhao Z, Gao H, et al. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly (amidoamine) dendrimer for the therapy of gliomas. Nanotheranostics. 2019;3(4):311. doi:10.7150/ntno.38954
   PubMedGoogle Scholar
• Singh AV, Maharjan R-S, Kanase A, et al. Machine-learning-based approach to decode the influence of nanomaterial properties on their interaction with cells. ACS Appl Mater Interfaces. 2020;13(1):1943–1955. doi:10.1021/acsami.0c18470
   PubMedGoogle Scholar
• Mariyam M, Ghosal K, Thomas S, Kalarikkal N, Latha MS. Dendrimers: general aspects, applications and structural exploitations as prodrug/drug-delivery vehicles in current medicine. Mini Rev Med Chem. 2018;18(5):439–457. doi:10.2174/1389557517666170512095151
   PubMedGoogle Scholar
• Muniswamy VJ, Raval N, Gondaliya P, Tambe V, Kalia K, Tekade RK. ‘Dendrimer-Cationized-Albumin’encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin. Int J Pharm. 2019;555:77–99. doi:10.1016/j.ijpharm.2018.11.035
   PubMedGoogle Scholar
• Santos A, Veiga F, Figueiras A. Dendrimers as pharmaceutical excipients: synthesis, properties, toxicity and biomedical applications. Materials. 2020;13(1):65. doi:10.3390/ma13010065
   Web of Science ®Google Scholar
• Hanafy NA, El-Kemary M, Leporatti S. Micelles structure development as a strategy to improve smart cancer therapy. Cancers. 2018;10(7):238. doi:10.3390/cancers10070238
   PubMed Web of Science ®Google Scholar
• Wakaskar RR. General overview of lipid–polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes. J Drug Target. 2018;26(4):311–318. doi:10.1080/1061186X.2017.1367006
   PubMed Web of Science ®Google Scholar
• Pantshwa JM, Kondiah PP, Choonara YE, Marimuthu T, Pillay V. Nanodrug Delivery Systems for the Treatment of Ovarian Cancer. Cancers. 2020;12(1):213. doi:10.3390/cancers12010213
   PubMed Web of Science ®Google Scholar
• Yu F, Jiang F, Tang X, Wang B. N-octyl-N-arginine-chitosan micelles for gambogic acid intravenous delivery: characterization, cell uptake, pharmacokinetics, and biodistribution. Drug Dev Ind Pharm. 2018;44(4):615–623. doi:10.1080/03639045.2017.1405973
   PubMed Web of Science ®Google Scholar
• Fathi M, Majidi S, Zangabad PS, Barar J, Erfan‐Niya H, Omidi Y. Chitosan‐based multifunctional nanomedicines and theranostics for targeted therapy of cancer. Med Res Rev. 2018;38(6):2110–2136. doi:10.1002/med.21506
   PubMed Web of Science ®Google Scholar
• Yan L, Li X. Biodegradable stimuli-responsive polymeric micelles for treatment of malignancy. Curr Pharm Biotechnol. 2016;17(3):227–236. doi:10.2174/138920101703160206142821
   PubMedGoogle Scholar
• Yin Y, Wang J, Yang M, et al. Penetration of the blood–brain barrier and the anti-tumour effect of a novel PLGA-lysoGM1/DOX micelle drug delivery system. Nanoscale. 2020;12(5):2946–2960. doi:10.1039/C9NR08741A
   PubMedGoogle Scholar
• Shiraishi K, Wang Z, Kokuryo D, Aoki I, Yokoyama M. A polymeric micelle magnetic resonance imaging (MRI) contrast agent reveals blood–brain barrier (BBB) permeability for macromolecules in cerebral ischemia-reperfusion injury. J Controlled Release. 2017;253:165–171. doi:10.1016/j.jconrel.2017.03.020
   PubMed Web of Science ®Google Scholar
• Sonali Agrawal P, Singh RP, Rajesh CV, et al. Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv. 2016;23(5):1788–1798. doi:10.3109/10717544.2015.1094681
   PubMedGoogle Scholar
• Mochida Y, Cabral H, Kataoka K. Polymeric micelles for targeted tumor therapy of platinum anticancer drugs. Expert Opin Drug Deliv. 2017;14(12):1423–1438. doi:10.1080/17425247.2017.1307338
   PubMed Web of Science ®Google Scholar
• Upponi JR, Jerajani K, Nagesha DK, et al. Polymeric micelles: theranostic co-delivery system for poorly water-soluble drugs and contrast agents. Biomaterials. 2018;170:26–36. doi:10.1016/j.biomaterials.2018.03.054
   PubMed Web of Science ®Google Scholar
• Agrawal P, Singh RP, Sharma G, et al. Bioadhesive micelles of d-α-tocopherol polyethylene glycol succinate 1000: synergism of chitosan and transferrin in targeted drug delivery. Colloids Surf B Biointerfaces. 2017;152:277–288. doi:10.1016/j.colsurfb.2017.01.021
   PubMed Web of Science ®Google Scholar
• Bhavna S, Ali M, Baboota S, et al. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm. 2014;40(2):278–287. doi:10.3109/03639045.2012.758130
   PubMed Web of Science ®Google Scholar
• Madan J, Pandey RS, Jain V, Katare OP, Chandra R, Katyal A. Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells. Nanomedicine. 2013;9(4):492–503. doi:10.1016/j.nano.2012.10.003
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen G, Wen L, et al. Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation. Eur J Pharmaceutical Sci. 2013;48(4–5):595–603. doi:10.1016/j.ejps.2013.01.007
   PubMed Web of Science ®Google Scholar
• Choonara YE, Pillay V, Ndesendo VM, et al. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloids Surf B Biointerfaces. 2011;87(2):243–254. doi:10.1016/j.colsurfb.2011.05.025
   PubMed Web of Science ®Google Scholar
• Pandey R, Khuller G. Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model. J Antimicrobial Chemotherapy. 2006;57(6):1146–1152. doi:10.1093/jac/dkl128
   PubMedGoogle Scholar
• Zhang -T-T, Li W, Meng G, Wang P, Liao W. Strategies for transporting nanoparticles across the blood–brain barrier. Biomater Sci. 2016;4(2):219–229. doi:10.1039/C5BM00383K
   PubMed Web of Science ®Google Scholar
• Barbara R, Belletti D, Pederzoli F, et al. Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates. Int J Pharm. 2017;526(1–2):413–424. doi:10.1016/j.ijpharm.2017.05.015
   PubMed Web of Science ®Google Scholar
• Malinovskaya Y, Melnikov P, Baklaushev V, et al. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. Int J Pharm. 2017;524(1–2):77–90. doi:10.1016/j.ijpharm.2017.03.049
   PubMed Web of Science ®Google Scholar
• Gao S, Tian H, Xing Z, et al. A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment. J Controlled Release. 2016;243:357–369. doi:10.1016/j.jconrel.2016.10.027
   PubMed Web of Science ®Google Scholar
• Mondal J, Patra M, Panigrahi AK, Khuda-Bukhsh AR. Boldine-loaded PLGA nanoparticles have improved efficiency of drug carriage and protective potential against Cisplatin-induced toxicity. J Ayurveda Integr Med. 2018;1:124.
   Google Scholar
• Varga N, Csapó E, Majláth Z, et al. Targeting of the kynurenic acid across the blood–brain barrier by core-shell nanoparticles. Eur J Pharmaceutical Sci. 2016;86:67–74. doi:10.1016/j.ejps.2016.02.012
   PubMedGoogle Scholar
• Guccione C, Oufir M, Piazzini V, et al. Andrographolide-loaded nanoparticles for brain delivery: formulation, characterisation and in vitro permeability using hCMEC/D3 cell line. Eur J Pharmaceutics Biopharmaceutics. 2017;119:253–263. doi:10.1016/j.ejpb.2017.06.018
   PubMedGoogle Scholar
• Englert C, Trützschler A-K, Raasch M, et al. Crossing the blood-brain barrier: glutathione-conjugated poly (ethylene imine) for gene delivery. J Controlled Release. 2016;241:1–14. doi:10.1016/j.jconrel.2016.08.039
   PubMed Web of Science ®Google Scholar
• He C, Cai P, Li J, et al. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer. J Controlled Release. 2017;246:98–109. doi:10.1016/j.jconrel.2016.12.019
   PubMed Web of Science ®Google Scholar
• Fernandes J, Ghate MV, Mallik SB, Lewis SA. Amino acid conjugated chitosan nanoparticles for the brain targeting of a model dipeptidyl peptidase-4 inhibitor. Int J Pharm. 2018;547(1–2):563–571. doi:10.1016/j.ijpharm.2018.06.031
   PubMedGoogle Scholar
• Li W, Cao Z, Liu R, et al. AuNPs as an important inorganic nanoparticle applied in drug carrier systems. Artif Cells, Nanomed Biotechnol. 2019;47(1):4222–4233. doi:10.1080/21691401.2019.1687501
   PubMed Web of Science ®Google Scholar
• Singh P, Pandit S, Mokkapati V, Garg A, Ravikumar V, Mijakovic I. Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci. 2018;19(7):1979. doi:10.3390/ijms19071979
   PubMed Web of Science ®Google Scholar
• Meola A, Rao J, Chaudhary N, Sharma M, Chang SD. Gold nanoparticles for brain tumor imaging: a systematic review. Front Neurol. 2018;9:328. doi:10.3389/fneur.2018.00328
   PubMed Web of Science ®Google Scholar
• Siddique S, Chow JC. Gold nanoparticles for drug delivery and cancer therapy. App Sci. 2020;10(11):3824. doi:10.3390/app10113824
   Google Scholar
• Gao Y, Li Y. Gold Nanostructures for Cancer Imaging and Therapy. Advances in Nanotheranostics I: Springer; 2016:53–101.
   Google Scholar
• Giljohann DA, Seferos DS, Daniel WL, Massich MD, Patel PC, Mirkin CA. Gold nanoparticles for biology and medicine. Spherical Nucleic Acids. 2020;55–90.
   Google Scholar
• Morshed RA, Muroski ME, Dai Q, et al. Cell-penetrating peptide-modified gold nanoparticles for the delivery of doxorubicin to brain metastatic breast cancer. Mol Pharm. 2016;13(6):1843–1854. doi:10.1021/acs.molpharmaceut.6b00004
   PubMed Web of Science ®Google Scholar
• Raliya R, Saha D, Chadha TS, Raman B, Biswas P. Non-invasive aerosol delivery and transport of gold nanoparticles to the brain. Sci Rep. 2017;7(1):1–8. doi:10.1038/srep44718
   PubMed Web of Science ®Google Scholar
• Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai UR, Graham D, Namdee K. Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood–brain barrier penetration. Sci Rep. 2019;9(1):1–9. doi:10.1038/s41598-019-44569-6
   PubMedGoogle Scholar
• Johnsen KB, Bak M, Kempen PJ, et al. Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles. Theranostics. 2018;8(12):3416. doi:10.7150/thno.25228
   PubMed Web of Science ®Google Scholar
• Jain S, Park SB, Pillai SR, Ryan PL, Willard ST, Feugang JM. Applications of fluorescent quantum dots for reproductive medicine and disease detection. Unraveling the Safety Profile of Nanoscale Particles and Materials—From Biomedical to Environmental Applications. 2018.
   Google Scholar
• Madni A, Batool A, Noreen S, et al. Novel nanoparticulate systems for lung cancer therapy: an updated review. J Drug Target. 2017;25(6):499–512. doi:10.1080/1061186X.2017.1289540
   PubMed Web of Science ®Google Scholar
• Sharma A, Sharma R, Bhatia N, Kumari A. Review on Synthesis, Characterization and Applications of Silver Sulphide Quantum Dots. J Mater Sci Res Rev. 2021;42–58.
   Google Scholar
• Cabral Filho PE, Cardoso AL, Pereira MI, et al. CdTe quantum dots as fluorescent probes to study transferrin receptors in glioblastoma cells. Biochimica et Biophysica Acta. 2016;1860(1):28–35. doi:10.1016/j.bbagen.2015.09.021
   PubMedGoogle Scholar
• Sikorska K, Grądzka I, Sochanowicz B, et al. Diminished amyloid-β uptake by mouse microglia upon treatment with quantum dots, silver or cerium oxide nanoparticles: nanoparticles and amyloid-β uptake by microglia. Hum Exp Toxicol. 2020;39(2):147–158. doi:10.1177/0960327119880586
   PubMedGoogle Scholar
• Norouzi M. Gold nanoparticles in glioma theranostics. Pharmacol Res. 2020;156:104753.
   PubMed Web of Science ®Google Scholar
• Zhou T, Huang Z, Wan F, Sun Y. Carbon quantum dots-stabilized Pickering emulsion to prepare NIR light-responsive PLGA drug delivery system. Mater Today Commu. 2020;23:100951. doi:10.1016/j.mtcomm.2020.100951
   Google Scholar
• Luo W, Wang Y, Lin F, et al. Selenium-Doped Carbon Quantum Dots Efficiently Ameliorate Secondary Spinal Cord Injury via Scavenging Reactive Oxygen Species. Int J Nanomedicine. 2020;15:10113. doi:10.2147/IJN.S282985
   PubMed Web of Science ®Google Scholar
• Chinnathambi S, Chen S, Ganesan S, Hanagata N. Silicon quantum dots for biological applications. Adv Healthcare Mater. 2014;3(1):10–29. doi:10.1002/adhm.201300157
   Google Scholar
• Madni A, Noreen S, Maqbool I, et al. Graphene-based nanocomposites: synthesis and their theranostic applications. J Drug Target. 2018;26(10):858–883. doi:10.1080/1061186X.2018.1437920
   PubMed Web of Science ®Google Scholar
• Chen J, Yu Q, Fu W, et al. A highly sensitive amperometric glutamate oxidase microbiosensor based on a reduced graphene oxide/prussian blue nanocube/gold nanoparticle composite film-modified pt electrode. Sensors. 2020;20(10):2924. doi:10.3390/s20102924
   PubMedGoogle Scholar
• Chen W, Huang L, Tang Q, Wang S, Hu C, Zhang X. Central Nervous System Tuberculosis: challenge and Perspective. Radiol Infect Dis. 2020. doi:10.1016/j.jrid.2020.07.005
   Google Scholar
• Saeedi M, Eslamifar M, Khezri K, Dizaj SM. Applications of nanotechnology in drug delivery to the central nervous system. Biomed Pharmacother. 2019;111:666–675. doi:10.1016/j.biopha.2018.12.133
   PubMed Web of Science ®Google Scholar
• Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives. Int J Nanomedicine. 2021;16:1313. doi:10.2147/IJN.S289443
   PubMed Web of Science ®Google Scholar
• DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):1–18. doi:10.1186/s13024-019-0333-5
   PubMed Web of Science ®Google Scholar
• Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener. 2020;15(1):1–37.
   PubMed Web of Science ®Google Scholar
• Giorgetti S, Greco C, Tortora P, Aprile FA. Targeting amyloid aggregation: an overview of strategies and mechanisms. Int J Mol Sci. 2018;19(9):2677. doi:10.3390/ijms19092677
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu L-P, Dai W, Dong H, Wen Y, Zhang X. Graphene quantum dots for the inhibition of β amyloid aggregation. Nanoscale. 2015;7(45):19060–19065. doi:10.1039/C5NR06282A
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu L-P, Wang Q, Yang B, Zhang X. Synergistic inhibitory effect of GQDs–tramiprosate covalent binding on amyloid aggregation. ACS Chem Neurosci. 2017;9(4):817–823. doi:10.1021/acschemneuro.7b00439
   Google Scholar
• Gómez-Benito M, Granado N, García-Sanz P, Michel A, Dumoulin M, Moratalla R. Modeling Parkinson’s disease with the alpha-synuclein protein. Front Pharmacol. 2020;2:11.
   Google Scholar
• Alegre-Abarrategui J, Brimblecombe KR, Roberts RF, et al. Selective vulnerability in α-synucleinopathies. Acta Neuropathol. 2019;138(5):681–704. doi:10.1007/s00401-019-02010-2
   PubMed Web of Science ®Google Scholar
• Yoo JM. Graphene Quantum Dots Prevent Α-Synucleinopathy in Parkinson’s Disease. Studies on Graphene-Based Nanomaterials for Biomedical Applications: Springer; 2020:29–64.
   Google Scholar
• Mars A, Hamami M, Bechnak L, Patra D, Raouafi N. Curcumin-graphene quantum dots for dual mode sensing platform: electrochemical and fluorescence detection of APOe4, responsible of Alzheimer’s disease. Anal Chim Acta. 2018;1036:141–146. doi:10.1016/j.aca.2018.06.075
   PubMed Web of Science ®Google Scholar
• Gao X, Chen J, Chen J, Wu B, Chen H, Jiang X. Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging. Bioconjug Chem. 2008;19(11):2189–2195. doi:10.1021/bc8002698
   PubMed Web of Science ®Google Scholar